Cargando…
Appraising risk in active surveillance of localized prostate cancer
OBJECTIVES: Men diagnosed with low‐risk prostate cancer are typically eligible for active surveillance of their cancer, involving monitoring for cancer progression and making judgements about the risks of prostate cancer against those of active intervention. Our study examined how risk for prostate...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803412/ https://www.ncbi.nlm.nih.gov/pubmed/31095822 http://dx.doi.org/10.1111/hex.12912 |
_version_ | 1783460924601925632 |
---|---|
author | Hogden, Anne Churruca, Kate Rapport, Frances Gillatt, David |
author_facet | Hogden, Anne Churruca, Kate Rapport, Frances Gillatt, David |
author_sort | Hogden, Anne |
collection | PubMed |
description | OBJECTIVES: Men diagnosed with low‐risk prostate cancer are typically eligible for active surveillance of their cancer, involving monitoring for cancer progression and making judgements about the risks of prostate cancer against those of active intervention. Our study examined how risk for prostate cancer is perceived and experienced by patients undergoing active surveillance with their clinicians, how risk is communicated in clinical consultations, and the implications for treatment and care. METHOD: Participants were nine patients and three clinicians from a university hospital urology clinic. A staged, qualitative, multi‐method data collection approach was undertaken, comprising: observations of consultations; patient and clinician interviews; and patient surveys. The three data sets were analysed separately using thematic analysis and then integrated to give a comprehensive view of patient and clinician views. RESULTS: Thirty data points (eight patient surveys; 10 observations of consultations between patients and clinicians; 10 patient interviews; and two clinician interviews) combined to create a detailed picture of how patients perceived and appraised risk, in three themes of “Making sense of risk”, “Talking about risk” and “Responding to risk”. CONCLUSION: Effective risk communication needs to be finely tuned and timed to individual patient's priorities and information requirements. A structured information exchange process that identifies patients' priorities, and details key moments in risk assessment, so that complexities of risk are discussed in ways that are meaningful to patients, may benefit patient care. These findings could inform the development of patient‐centric risk assessment procedures and service delivery models in prostate cancer care more broadly. |
format | Online Article Text |
id | pubmed-6803412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68034122019-10-24 Appraising risk in active surveillance of localized prostate cancer Hogden, Anne Churruca, Kate Rapport, Frances Gillatt, David Health Expect Original Research Papers OBJECTIVES: Men diagnosed with low‐risk prostate cancer are typically eligible for active surveillance of their cancer, involving monitoring for cancer progression and making judgements about the risks of prostate cancer against those of active intervention. Our study examined how risk for prostate cancer is perceived and experienced by patients undergoing active surveillance with their clinicians, how risk is communicated in clinical consultations, and the implications for treatment and care. METHOD: Participants were nine patients and three clinicians from a university hospital urology clinic. A staged, qualitative, multi‐method data collection approach was undertaken, comprising: observations of consultations; patient and clinician interviews; and patient surveys. The three data sets were analysed separately using thematic analysis and then integrated to give a comprehensive view of patient and clinician views. RESULTS: Thirty data points (eight patient surveys; 10 observations of consultations between patients and clinicians; 10 patient interviews; and two clinician interviews) combined to create a detailed picture of how patients perceived and appraised risk, in three themes of “Making sense of risk”, “Talking about risk” and “Responding to risk”. CONCLUSION: Effective risk communication needs to be finely tuned and timed to individual patient's priorities and information requirements. A structured information exchange process that identifies patients' priorities, and details key moments in risk assessment, so that complexities of risk are discussed in ways that are meaningful to patients, may benefit patient care. These findings could inform the development of patient‐centric risk assessment procedures and service delivery models in prostate cancer care more broadly. John Wiley and Sons Inc. 2019-05-16 2019-10 /pmc/articles/PMC6803412/ /pubmed/31095822 http://dx.doi.org/10.1111/hex.12912 Text en © 2019 The Authors Health Expectations published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Papers Hogden, Anne Churruca, Kate Rapport, Frances Gillatt, David Appraising risk in active surveillance of localized prostate cancer |
title | Appraising risk in active surveillance of localized prostate cancer |
title_full | Appraising risk in active surveillance of localized prostate cancer |
title_fullStr | Appraising risk in active surveillance of localized prostate cancer |
title_full_unstemmed | Appraising risk in active surveillance of localized prostate cancer |
title_short | Appraising risk in active surveillance of localized prostate cancer |
title_sort | appraising risk in active surveillance of localized prostate cancer |
topic | Original Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803412/ https://www.ncbi.nlm.nih.gov/pubmed/31095822 http://dx.doi.org/10.1111/hex.12912 |
work_keys_str_mv | AT hogdenanne appraisingriskinactivesurveillanceoflocalizedprostatecancer AT churrucakate appraisingriskinactivesurveillanceoflocalizedprostatecancer AT rapportfrances appraisingriskinactivesurveillanceoflocalizedprostatecancer AT gillattdavid appraisingriskinactivesurveillanceoflocalizedprostatecancer |